Showing 1 - 12 results of 12 for search 'Mark A Turner', query time: 0.03s
Refine Results
-
1
Inequalities and stillbirth in the UK: a meta-narrative review by Claire Storey, Carol Kingdon, Soo Downe, Mark A Turner, Devender Roberts, Nicola Crossland, Kenneth William Finlayson
Published 2019-09-01Get full text
Article -
2
Enhancing communication about paediatric medicines: lessons from a qualitative study of parents' experiences of their child's suspected adverse drug reaction. by Janine Arnott, Hannah Hesselgreaves, Anthony J Nunn, Matthew Peak, Munir Pirmohamed, Rosalind L Smyth, Mark A Turner, Bridget Young
Published 2012-01-01Get full text
Article -
3
Experience and lessons learned relating to investigational product supply in the design and delivery of a paediatric investigator-initiated clinical trial by Mandy Wan, Mark A. Turner, Gilles Cambonie, Ruth Kemper, Naouel Bouafia, Lea Levoyer, Alpha Diallo, Mikko Hallman, Jean-Christophe Rozé
Published 2025-08-01Get full text
Article -
4
-
5
Developing and streamlining clinical trial services to support pediatric drug development across 21 countries in Europe: insights from the conect4children (c4c) network by Sabah Attar, Sabah Attar, Francisca P. Figueiras, Francisca P. Figueiras, Carla Peacock, Hazel Wohlfahrt, Birgitta C. P. Hüsken, Susan Andrews, Pirkko Lepola, Margaret Patton, Regis Hankard, Eren Halil, Fernando Pontes Soares, Lionel K. Tan, Ricardo M. Fernandes, Ricardo M. Fernandes, Mark A. Turner, Mark A. Turner
Published 2025-06-01Get full text
Article -
6
Mechanism-based urinary biomarkers to identify the potential for aminoglycoside-induced nephrotoxicity in premature neonates: a proof-of-concept study. by Stephen J McWilliam, Daniel J Antoine, Venkata Sabbisetti, Mark A Turner, Tracey Farragher, Joseph V Bonventre, B Kevin Park, Rosalind L Smyth, Munir Pirmohamed
Published 2012-01-01Get full text
Article -
7
-
8
Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool. by Ruairi M Gallagher, Jamie J Kirkham, Jennifer R Mason, Kim A Bird, Paula R Williamson, Anthony J Nunn, Mark A Turner, Rosalind L Smyth, Munir Pirmohamed
Published 2011-01-01Get full text
Article -
9
-
10
The WHEAT pilot trial—WithHolding Enteral feeds Around packed red cell Transfusion to prevent necrotising enterocolitis in preterm neonates: a multicentre, electronic patient recor... by Neena Modi, Jon Dorling, Chris Gale, Tjeerd Van Staa, Louise Linsell, Ursula Bowler, Ed Juszczak, Mark A Turner, Sena Jawad, Amanda Forster, Andy King, Jenny McLeish, Helen Robberts, Kayleigh Stanbury
Published 2019-09-01Get full text
Article -
11
Requirements and special considerations for drug trials with children across six jurisdictions: 1. Clinical trial application review in the regulatory approval process by Breanne Stewart, Pirkko Lepola, Gunter F. Egger, Fahimeda Ali, Albert J. Allen, Albert J. Allen, Alysha K. Croker, Andrew J. Davidson, Pamela Dicks, Saul N. Faust, Saul N. Faust, Dionna Green, Collin Hovinga, Collin Hovinga, Agnes V. Klein, Robyn Langham, Hidefumi Nakamura, Laura Pioppo, Shiva Ramroop, Michiyo Sakiyama, Isabel Sanchez Vigil de la Villa, Junko Sato, Donna L. Snyder, Mark A. Turner, Mark A. Turner, Sarah Zaidi, Kanecia Zimmerman, Kanecia Zimmerman, Thierry Lacaze-Masmonteil
Published 2025-04-01Get full text
Article -
12
Requirements and special considerations for drug trials with children across six jurisdictions: 2. Ethics review in the regulatory approval process by Breanne Stewart, Pirkko Lepola, Gunter F. Egger, Fahimeda Ali, Albert J. Allen, Albert J. Allen, Alysha K. Croker, Andrew J. Davidson, Pamela Dicks, Saul N. Faust, Saul N. Faust, Dionna Green, Collin Hovinga, Collin Hovinga, Agnes V. Klein, Robyn Langham, Hidefumi Nakamura, Laura Pioppo, Shiva Ramroop, Michiyo Sakiyama, Isabel Sanchez Vigil de la Villa, Junko Sato, Donna L. Snyder, Mark A. Turner, Mark A. Turner, Sarah Zaidi, Kanecia Zimmerman, Kanecia Zimmerman, Thierry Lacaze-Masmonteil
Published 2025-02-01Get full text
Article